new glp 1 medication FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic GLP-1 Weight Loss Treatment |

We estimate that this could lead to a cost saving of 1.4% of GDP or over $400 billion annually.1 The UK government is already talking about GLP-1s as one of the key ways to reduce the burden on the NHS and increase productivity as they create a reform plan for the future of the nations healthcare

Cancer Immunol Immunother (2009) 58(11):172347

Email responses came within 24 hours

Clinical trials show that Ozempic leads to substantially greater weight reduction, while metformin typically results in more modest weight loss

Adolescent preferences for weight terminology used by health care providers

If youre part of a TrimRX program, youll also benefit from personalized support and guidance on injection techniques tailored to your needs